Ocera Therapeutics (Nasdaq:OCRX) today announced that it has entered into a Technology Transfer and License Agreement with the Roche Group, including the Research and Early Development arms of both Genentech and Roche, for rights to its ...
Tags: Ocera Therapeutics, Roche, Macrocyclic Template Chemistry
The United States has one of the most advanced economies yet has one of the most inefficient healthcare systems, a study by U.S. and Canadian researchers found. Dr. Jody Heymann, the study's senior author and dean of the University of ...
BIND Therapeutics, a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, has amended its development and commercialization collaboration agreement with Amgen to extend the period ...
Covagen has announced that the company has secured CHF42m in a tranched Series B financing with an option to obtain an additional CHF14m that would increase the total amount of the financing round to CHF56m. This financing will mainly ...
Druggability Technologies (DRGT) has entered into a multi-year collaboration deal with Bayer HealthCare that will deploy DRGT's proprietary Super-API platform to support Bayer HealthCare's formulation efforts directed at enhancing compound ...
Tags: Drugs Discovery, Bayer Healthcare
The McMaster cexplored the freight village concept and its potential applications to Ontario during the Freight Hub symposium last week. PhD candidate Chris Higgins outlined the key benefits freight villages can provide to an array of ...
Tags: Transportation, Auto Parts
Linkam Scientific Instruments report on the use of their stages for supramolecular polymer research at the Eindhoven University of Technology in the Netherlands. As part of the Supramolecular polymer chemistry group at the Eindhoven ...
Tags: supramolecular, Linkam
NanoViricides has received results of detailed lab analysis studies from the initial non-GLP toxicology studies of intravenously administered FluCide. No overt adverse safety and toxicology effects were observed in this study of the ...
Taiwan-based JHL Biotech and Switzerland-based Selexis have formed a biologic drug development alliance to serve the biopharmaceutical industry. JHL Biotech and Selexis have signed a non-exclusive strategic agreement to provide seamless ...
Tags: Health, Medicine, taiwan, Biologic Drug
CDRD Ventures, the commercialization vehicle of The Centre for Drug Research and Development (CDRD), has announced the launch of a new spin-off company, Sitka Biopharma is a biotechnology company developing a new bladder cancer treatment. ...
The US Food and Drug Administration (FDA) has granted orphan drug designation to Conatus Pharmaceuticals' drug candidate emricasan for the treatment of liver transplant patients with reestablished fibrosis to delay the progression to ...
Mexican food manufacturer Mission Foods plans to expand its factory in the Coventry Business Park by 6,200ft2, while creating more than 50 new job Owned by Mexican food group Gruma, the company manufactures tortillas and wraps for retail ...
Tags: Mission Foods, Manufacturing Plant
DBV Technologies, creator of Viaskin, has entered into a collaboration agreement with BioNet-Asia and the University of Geneva (UNIGE) to work on a whooping cough (pertussis) booster vaccine. The clinical proof of concept product ...
Tags: DBV Technologies, Booster Vaccine
Canada-based ImStar Therapeutics has announced the selection of IMS-088 as its lead drug candidate for the treatment of amyotrophic lateral sclerosis. IMS-088 is a novel, small-molecule drug that stems from the discovery of a new target ...
The European Medicines Agency (EMA) has fully validated and granted accelerated assessment to Boehringer Ingelheim's application for European marketing authorization of faldaprevir, a potent second generation oral protease inhibitor. ...